Exane Derivatives Checkpoint Therapeutics, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Checkpoint Therapeutics, Inc. stock. As of the latest transaction made, Exane Derivatives holds 1,611 shares of CKPT stock, worth $5,702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,611
Previous 28,853
94.42%
Holding current value
$5,702
Previous $51,000
98.04%
% of portfolio
0.0%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding CKPT
# of Institutions
3Shares Held
1.91MCall Options Held
0Put Options Held
0About Checkpoint Therapeutics, Inc.
- Ticker CKPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,497,000
- Market Cap $303M
- Description
- Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...